Kidney Cancer UK represents patients at NICE nivo+ipi appraisalIpilimumab| NICE| NivolumabOn 3rd February 2022, NICE approve the use of nivolumab with ipilimumab as a first line treatment for kidney ...
NICE rejects pembro+axitinib therapy for aRCCAxitinib| NICE| PembrolizumabKidney cancer community strongly disagrees with NICE decision not to approve pembrolizumab with axitinib ...
NICE: Shared decision makinghealth| NICE| oncology| RCC| renalAuthor: Susanna Smith; BSc (Hons) Nursing and MSc Public Health Kidney Cancer UK Health Professional I recently ...
How we work with N.I.C.ECheckmate214| Health Professional| NICEHow Kidney Cancer UK works with N.I.C.E to bring new drugs treatments to patients Author; Lucy Willingale Bsc ...
NICE recommend nivolumab + ipilimumab combo through CDFIpilimumab| NICE| Nivolumab Bristol-Myers Squibb has announced that the National Institute for Health and Care Excellence (NICE) has ...
Kidney Cancer UK represents patients at NICE appraisalsNICEOn the 10th May 2018 the National Institute for Care and Health Excellence (NICE) appraised two different drug ...
NICE recommends tivozanib as first-line treatment for advanced renal cell carcinomaNICE| TivozanibEUSA Pharma has announced that the National Institute for Health and Care Excellence (NICE) has published a Final ...
Hopes for Cabozantinib NICE recommendationCabozantinib| NICE| SorafenibKidney Cancer UK is very disappointed to hear that at the midpoint of the Single Technology Appraisal (STA) of ...
Cabozantinib unlikely to be recommended based on cost: NICE and Ipsen in talksCabozantinib| NICENICE and Ipsen are continuing to discuss whether cabozantinib (Cabometyx) is to be recommended for use on the NHS ...
NICE approves kidney cancer drug for NHS useNICEPatients with advanced kidney cancer will have routine NHS access to the drug everolimus following recommendations ...
NICE recommends nivolumabNICE| NivolumabNICE recommends nivolumab: Kidney Cancer UK is delighted that National Institute for Health and Care Excellence ...
New drug cabozantinib for treating advanced kidney cancer under NICE review.Cabozantinib| NICENew drug cabozantinib, for use in treating advanced kidney cancer (approved by the FDA in the USA), is currently ...